Harvard Bioscience | 10-Q: Quarterly report
Harvard Bioscience Inc (HBIO) Q1 2024 Earnings: Challenges Persist Amidst Strategic Adjustments
Earnings Flash (HBIO) HARVARD BIOSCIENCE Posts Q1 EPS $0.02
07:18 AM EDT, 05/07/2024 (MT Newswires) -- Earnings Flash (HBIO) HARVARD BIOSCIENCE Posts Q1 EPS $0.02
Express News | Harvard Bioscience - Expect H2 Growth Vs Both H1 of 2024 and H2 2023, Supported by New Product Commercializations & Expected Improvements in China
Express News | Harvard Bioscience Inc - for Full Year 2024 We Expect Revenues to Be Approximately Flat Versus 2023
Express News | Harvard Bioscience Continues To Expect 2024 Gross Margin Of Approximately 60% And Adjusted EBITDA Margin In The Mid-teens
Harvard Bioscience Sees FY24 Revenues Approximately Flat Versus 2023 >HBIO
Harvard Bioscience Sees FY24 Revenues Approximately Flat Versus 2023 >HBIO
Express News | Harvard Bioscience Announces First Quarter 2024 Financial Results
Express News | Harvard Bioscience Q1 Revenue USD 24.5 Million
Harvard Bioscience 1Q Adj EPS 2c >HBIO
Harvard Bioscience 1Q Adj EPS 2c >HBIO
Press Release: Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ET
Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ET HOLLISTON, Mass., April 29, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) wil
Harvard Bioscience Announces Labor Force Reduction
Express News | Harvard Bioscience Expects Overall Run Rate Savings Of ~$4M Beginning In Q2 2024; Expects Q2 Restructuring-Related Charges Of ~$0.5M
Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth
HOLLISTON, Mass., April 09, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced a labor force reduction to improve its operating cost structure and support its ongoing i
Harvard Bioscience Sets Incentive Plan for Top Executives
Investing in Harvard Bioscience (NASDAQ:HBIO) a Year Ago Would Have Delivered You a 25% Gain
Sidoti Events, LLC's Virtual March Small-Cap Conference
Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti's Small Cap Conference and KeyBanc's Life Sciences & MedTech Conference
HOLLISTON, Mass., March 11, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, will be presenting to investors at
Is There An Opportunity With Harvard Bioscience, Inc.'s (NASDAQ:HBIO) 34% Undervaluation?
Harvard Bioscience Q4 Adj EPS $0.04 Misses $0.05 Estimate, Sales $28.15M Miss $29.11M Estimate
Harvard Bioscience (NASDAQ:HBIO) reported quarterly earnings of Adj $0.04 per share which missed the analyst consensus estimate of $0.05 by 20 percent. This is unchanged from the same period last year
No Data